BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Neuro3d 

130, rue de la Mer Rouge

Mulhouse    F-68200  France
Phone: 33-0-389-36-91-70 Fax: 33-0-389-36-91-78


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Evotec AG Announces the Acquisition of all Shares of Neuro3d 3/29/2007 11:48:44 AM
Neuro3d Reports Positive Results From Phase II Trials Of Ocaperidone In Schizophrenia10/19/2005 5:13:15 PM
Neuro3d Initiates Phase I Trials With ND7001, A New Mechanism Antidepressant And Anxiolytic Compound10/19/2005 5:12:32 PM
Neuro3d's Third Round: EUR31.5M For Development Of Lead Drugs10/19/2005 5:11:51 PM
BioPartnering Europe 2004 Exhibitor Profiles10/19/2005 5:11:47 PM
Neuro3d Commences Clinical Studies With Its PDE4 Inhibitor ND1251 A New Approach For Treating Patients With Depression10/19/2005 5:11:34 PM
Neuro3d Completes A EUR 31.5 Million Third Round Financing10/19/2005 5:10:53 PM
Neuro3d Receives Support From ANVAR For Ongoing Clinical Development Of Its Antidepressant ND125110/19/2005 5:08:59 PM
Neuro3d Identifies Candidate Compound And Extends Collaboration10/19/2005 5:08:50 PM